Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Safety evaluation of 10 μg recombinant hepatitis B vaccine (saccharomyces cerecisiae yeast) based on the results of a phase of Ⅳ clinical trial].
Zeng Y, Zhang JK, Tang Y, Yang ZH, Su JL, Chen LY, Huang ZH, Zeng PY, Jian ZY, Du WM, Yang MW, Wang TT, Wang FZ, Liang XF, Zheng HZ. Zeng Y, et al. Among authors: zhang jk. Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Dec 6;51(12):1121-1123. doi: 10.3760/cma.j.issn.0253-9624.2017.12.014. Zhonghua Yu Fang Yi Xue Za Zhi. 2017. PMID: 29262496 Chinese. No abstract available.
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously With Hepatitis B Vaccine and Group A Meningococcal Polysaccharide Vaccine: A Phase 4, Open-Label, Single-Center, Randomized, Noninferiority Trial.
Zhang Z, Liang Z, Zeng J, Zhang J, He P, Su J, Zeng Y, Fan R, Zhao D, Ma W, Zeng G, Zhang Q, Zheng H. Zhang Z, et al. J Infect Dis. 2019 Jul 2;220(3):392-399. doi: 10.1093/infdis/jiz129. J Infect Dis. 2019. PMID: 30891604 Clinical Trial.
Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis.
Yang J, Zhang J, Fan R, Zhao W, Han T, Duan K, Li X, Zeng P, Deng J, Zhang J, Yang X. Yang J, et al. Front Immunol. 2020 Dec 4;11:603337. doi: 10.3389/fimmu.2020.603337. eCollection 2020. Front Immunol. 2020. PMID: 33343577 Free PMC article. Clinical Trial.
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.
Zhang J, Hu Z, He J, Liao Y, Li Y, Pei R, Fang X, Zeng P, Fan R, Ou Z, Deng J, Zhou J, Guan W, Min Y, Deng F, Peng H, Zhang Z, Feng C, Xin B. Zhang J, et al. Emerg Microbes Infect. 2021 Dec;10(1):1589-1597. doi: 10.1080/22221751.2021.1951126. Emerg Microbes Infect. 2021. PMID: 34197281 Free PMC article. Clinical Trial.
Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.
Shu YJ, He JF, Pei RJ, He P, Huang ZH, Chen SM, Ou ZQ, Deng JL, Zeng PY, Zhou J, Min YQ, Deng F, Peng H, Zhang Z, Wang B, Xu ZH, Guan WX, Hu ZY, Zhang JK. Shu YJ, et al. Among authors: zhang z, zhang jk. Chin Med J (Engl). 2021 Jul 22;134(16):1967-1976. doi: 10.1097/CM9.0000000000001702. Chin Med J (Engl). 2021. PMID: 34310400 Free PMC article. Clinical Trial.
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.
Fan R, Huang X, Nian X, Ou Z, Zhou J, Zhang J, Zeng P, Zhao W, Deng J, Chen W, Chen S, Duan K, Chen Y, Li X, Zhang J, Yang X. Fan R, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9. doi: 10.1080/21645515.2021.1967041. Epub 2021 Sep 2. Hum Vaccin Immunother. 2022. PMID: 34473607 Free PMC article. Clinical Trial.
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
Zhao Z, Liao Y, Li Y, Jiang G, Huang Z, Yang H, Ou Z, Yin Q, Chen J, Deng Y, Jiang R, Che Y, Li Q, Zheng H, Zhang J. Zhao Z, et al. Vaccine. 2022 Aug 5;40(33):4709-4715. doi: 10.1016/j.vaccine.2022.06.027. Epub 2022 Jun 24. Vaccine. 2022. PMID: 35753838 Clinical Trial.
Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial.
Shu Y, Yu Y, Ji Y, Zhang L, Li Y, Qin H, Huang Z, Ou Z, Huang M, Shen Q, Li Z, Hu M, Li C, Zhang G, Zhang J. Shu Y, et al. Vaccine. 2022 Nov 15;40(48):6947-6955. doi: 10.1016/j.vaccine.2022.10.022. Epub 2022 Oct 22. Vaccine. 2022. PMID: 36283897 Free article. Clinical Trial.
299 results